The impact of R&D outsourcing on innovation performance of Chinese pharmaceutical enterprises: incentives or inhibitionsSHU Yan, ZHANG Kai-yi1205-1210
Brexanolone: a new drug for adult women with postpartum depressionZHAO Xiao-juan, ZHOU Li-ming, WANG Yong-jing, ZHAO Yong-hong, HE Wen-juan1216-1221
Introduction and consideration of communication during the clinical trial of new drugs in the U.S.WANG Jing-can, WEN Bao-shu, CHEN Cheng-li1222-1226
Considerations on new drug application for anti-chronic lymphocytic leukemia drug from single arm trialZOU Li-min, TANG Ling, QI Yue-li, DU Yu, YANG Zhi-min1227-1230
Impurity control strategy of β-1actam antibiotics polymer:the formation and developmentHU Chang-qin1231-1244
Considerations of the analytical method selection for biological samples of peptide drugZHAI Jian-ping, DONG Li-hou, XIANG Shen-si, LI Li, GE Zhi-qiang1245-1250
Stability study of haemophilus influenzae type b conjugate vaccineCHEN Zhong-wei, LIU Xiao-lei, WANG Zhen-ye, LIU Feng, CHU Zi-qing, MU Shan-shan, SUN Shu-xue1251-1256
Advances in structural modification and structure-activity relationship of berberineWU Long-long, FANG Fang1257-1264